The estimated Net Worth of Thomas Ciulla is at least $1.03 Milione dollars as of 20 January 2023. Dr Ciulla owns over 13,700 units of Clearside Biomedical Inc stock worth over $382,376 and over the last 4 years he sold CLSD stock worth over $59,315. In addition, he makes $589,766 as Chief Medical Officer & Chief Devel. Officer at Clearside Biomedical Inc.
Sign up
Dr D CLSD stock SEC Form 4 insiders trading
Dr has made over 4 trades of the Clearside Biomedical Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 13,700 units of CLSD stock worth $20,139 on 20 January 2023.
The largest trade he's ever made was selling 13,700 units of Clearside Biomedical Inc stock on 20 January 2023 worth over $20,139. On average, Dr trades about 3,926 units every 69 days since 2021. As of 20 January 2023 he still owns at least 291,890 units of Clearside Biomedical Inc stock.
You can see the complete history of Dr Ciulla stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Thomas A. Ciulla M.B.A., M.D. biography
Dr. Thomas A. Ciulla M.B.A., M.D. is the Chief Medical Officer & Chief Devel. Officer at Clearside Biomedical Inc.
What is the salary of Dr D?
As the Chief Medical Officer & Chief Devel. Officer of Clearside Biomedical Inc, the total compensation of Dr D at Clearside Biomedical Inc is $589,766. There are 4 executives at Clearside Biomedical Inc getting paid more, with George Lasezkay having the highest compensation of $1,059,190.
How old is Dr D?
Dr D is 57, he's been the Chief Medical Officer & Chief Devel. Officer of Clearside Biomedical Inc since . There are 7 older and 5 younger executives at Clearside Biomedical Inc. The oldest executive at Clearside Biomedical Inc is Nancy Hutson, 70, who is the Independent Director.
What's Dr D's mailing address?
Thomas's mailing address filed with the SEC is C/O CLEARSIDE BIOMEDICAL, INC., 900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GA, 30005.
Insiders trading at Clearside Biomedical Inc
Over the last 8 years, insiders at Clearside Biomedical Inc have traded over $11,999,807 worth of Clearside Biomedical Inc stock and bought 4,477,928 units worth $22,264,136 . The most active insiders traders include Bradford T Whitmore, Clay Thorp e Venture Advisors Iv Sbic, L.... On average, Clearside Biomedical Inc executives and independent directors trade stock every 30 days with the average trade being worth of $82,593. The most recent stock trade was executed by Ngai Hang Victor Chong on 24 June 2024, trading 23,500 units of CLSD stock currently worth $24,910.
What does Clearside Biomedical Inc do?
clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.
What does Clearside Biomedical Inc's logo look like?
Complete history of Dr Ciulla stock trades at Clearside Biomedical Inc
Clearside Biomedical Inc executives and stock owners
Clearside Biomedical Inc executives and other stock owners filed with the SEC include:
-
George Lasezkay,
President, Chief Executive Officer, Director -
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.,
Pres, CEO & Director -
Dr. George M. Lasezkay Pharm.D., Pharma.D., J.D.,
Pres, CEO & Director -
Charles Deignan,
Chief Financial Officer -
Dr. Thomas A. Ciulla M.B.A., M.D.,
Chief Medical Officer & Chief Devel. Officer -
Charles A. Deignan,
Chief Financial Officer -
Jenny Kobin,
IR Contact Officer -
Clay Thorp,
Independent Director -
Nancy Hutson,
Independent Director -
William Humphries,
Independent Director -
Jeffrey Edwards,
Independent Director -
Richard Croarkin,
Independent Director -
Christy Shaffer,
Independent Chairman of the Board -
Susan L. Coultas Ph.D.,
Chief Clinical Officer -
Rick McElheny,
VP of Corp. Devel. -
Leslie B. Zacks,
Gen. Counsel, Chief Compliance Officer & Sec. -
Jenny R. Kobin,
Head of Investor Relations -
Venture Advisors Iii, Llc H...,
-
Venture Advisors Iv Sbic, L...,
-
Venture Advisors Iii, Llc H...,
-
Evgeny Zaytsev,
Director -
Daniel H. White,
President and CEO -
Investments S.A.R.L.Rusnano...,
-
Derek Yoon,
Director -
Gerald D. Cagle,
Director -
Venture Advisors Iv Sbic, L...,
-
Glenn Noronha,
Executive Vice President, R&D -
Thomas Ciulla,
Chief Medical Officer -
Brion S. Raymond,
Chief Commercial Officer -
Anthony S Gibney,
-
Bradford T Whitmore,
10% owner -
Ngai Hang Victor Chong,
Chief Medical Officer -
Benjamin R Yerxa,